APA |
Dangerous infections found in blood of 210 donors during blood donation …
APA Dangerous infections found in blood of 210 donors during blood donation campaign on Ashura Day in Azerbaijan. [ 21 November 2013 17:52 ]. Baku. Konul Kamilgizi – APA. “Dangerous infections were found in the blood of 210 out of 4437 people who … |
'Beware of fried foods' – Times of India
|
‘Beware of fried foods’
Times of India RELATED. HYDERABAD: Fast foods kill fast. Fried foods kill fast. Endocrinologist Dr Shashank Joshi who made a presentation on ‘Edible oils – suitable for Indian cooking condition’ sounded the alarm bell for the Indian palate which simply relishes fried … |
Syntermed's SyncTool™ Software to Be Used in International Heart Failure … – HispanicBusiness.com
|
Syntermed’s SyncTool™ Software to Be Used in International Heart Failure …
HispanicBusiness.com Syntermed, Inc. , announced today that their SyncTool™ nuclear cardiology imaging software is being used in a large global clinical trial for the diagnosis of heart failure. The VISION-CRT trial, sponsored by the International Atomic Energy Agency … |
Doctors hail heart failure meds decision – Newcastle Herald
|
Doctors hail heart failure meds decision
Newcastle Herald A NEWCASTLE cardiologist says the federal government’s decision to subsidise a heart failure medication will make a big difference to many sufferers. The drug Coralan, which slows the patient’s heart rate, will be listed on the PBS from December 1 … Heart drug help for Illawarra patientsIllawarra Mercury |
Syntermed's SyncTool™ Software to Be Used in International Heart Failure … – PR Web (press release)
|
Syntermed’s SyncTool™ Software to Be Used in International Heart Failure …
PR Web (press release) Syntermed, Inc. announces their SyncTool nuclear cardiology imaging software is being used in the VISION-CRT clinical trial with sites in nine countries. SyncTool is a phase analysis software tool that analyzes the benefits of cardiac resynchronization … |
Entertainment listings, Nov. 21-28, 2013 – Champaign/Urbana News-Gazette
|
Entertainment listings, Nov. 21-28, 2013
Champaign/Urbana News-Gazette Freewill donation. Christmas walk, 3 to 7 p.m., features eight beautifully decorated homes. Pre-purchase tickets for $10 at Lori’s Pins and Needles, Pearman Pharmacy, Shank’s Paint and Glass. Maps at Edgar County Historical Society, 414 N. Main St … |
Supplement linked to liver failure, hepatitis recalled – UPI.com
Food Safety News |
Supplement linked to liver failure, hepatitis recalled
UPI.com “As soon as we suspected a possible link between OxyElite Pro products and cases of liver failure and non-viral hepatitis in Hawaii, we warned the public and immediately began an investigation with state officials and the Centers for Disease Control … Woman files suit in dietary supplement case tied to liver failureHonolulu Star-Advertiser Diet Supplement Recalled After Being Linked to Liver Failure and DeathFood Consumer OxyElite Pro Supplements RecalledFDA.gov Food Safety News –Courthouse News Service all 80 news articles » |
Girl, seven, died of liver and heart failure three days after medics … – Daily Mail
Daily Mail |
Girl, seven, died of liver and heart failure three days after medics …
Daily Mail But despite having blue lips – a sign of organ failure – Dr Raka Banerjee said the schoolgirl was ‘fine’ and sent her home. Discharged: Simran Dhesi, seven, was released from the Accident and Emergency department at Sandwell … But the following day … Parents of tragic Simran say lessons must be learnedexpressandstar.com |
Girl, seven, died of liver and heart failure three days after bungling medics … – Daily Mail
|
Girl, seven, died of liver and heart failure three days after bungling medics …
Daily Mail But despite having blue lips – a sign of organ failure – Dr Raka Banerjee said the schoolgirl was ‘fine’ and sent her home. Discharged: Simran Dhesi, seven, was released from the Accident and Emergency department at Sandwell … But the following day … |
Cadila launches Mycidac-C for treatment of lung cancer – NetIndian
|
Cadila launches Mycidac-C for treatment of lung cancer
NetIndian “Mycidac-C is an innovative research product for the patients suffering from Non Small Cell Lung Cancer (NSCLC). The drug has been approved for launch in India by the Drug Controller General of India (DCGI). It targets Desmocolin-3, a novel target … |